Recursion Pharmaceuticals (NASDAQ: RXRX), a biotech focused on artificial intelligence (AI), became a publicly traded company in 2021 -- a time when AI did not grab nearly as much ...
Recursive digital selves underpin targeted advertising, predictive policing, and workplace monitoring. In each case, the opacity of algorithmic loops raises concerns about fairness, transparency, and ...
Cryptopolitan on MSN
Idle LLMs turn into builders, scientists, or philosophers
A new study from TU Wien shows that LLMs do not idle into nonsense when left without tasks. Instead, they fall into clear behavioral patterns.
MIT projects that by 2030, almost half of all consumer decision-making will be AI-driven. At The Drum Live, futurist Danielle Dodoo shares what that means for brands that have spent decades marketing ...
The CPG marketer, in partnership with data firm Vidmob, found that predictive impact scoring can boost creative performance and media ROI.
Transformer on MSN
When AI starts writing itself
Those pyrotechnic narratives may be science fiction, but the underlying mechanism — AI autonomously developing new, better AI — is considered one of the greatest risks inherent in our headlong rush to ...
Get the latest analysis on Hims & Hers Health, Inc. stock with valuation insights, business risks, and forecasts. Click here to find out why HIMS is a Hold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results